文献速递肾移植

稳定肾移植受者血浆NGAL水平与移植物丢失风险

Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

本研究纳入709例移植后超过2个月的稳定门诊肾移植受者,评估血浆及尿NGAL与钙卫蛋白对死亡删失移植物丢失的预测价值,随访58个月。血浆NGAL对5年内移植物丢失的预测能力最佳,AUC为0.795;

要点

  • 58个月时血浆NGAL预测移植物丢失的AUC为0.795,基于血肌酐的eGFR的AUC为0.866。

核心结论

  • 血浆NGAL是单中心稳定肾移植受者移植物丢失的独立预测因子,但与包括eGFR在内的基线预测因子相比未显示一致的附加价值。

研究设计与样本

  • 单中心研究,纳入709例移植后超过2个月的稳定门诊肾移植受者,随访58个月,评估血浆及尿NGAL与钙卫蛋白对死亡删失移植物丢失的预测价值。

主要发现

  • 血浆NGAL是唯一5年内移植物丢失AUC>0.7的生物标志物;58个月时血浆NGAL的AUC为0.795,基于血肌酐的eGFR的AUC为0.866。
  • 在传统危险因素和eGFR基础上加入log2(pNGAL)的无分类净重分类改善为54.3%(95%CI 9.2%-99.3%),但C统计量无显著改善。

局限性

  • 原文自述为单中心研究。
  • 原文自述未来需在更大队列中开展研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to investigate the utility of neutrophil gelatinase-associated lipocalin (NGAL) and calprotectin (CPT) to predict long-term graft survival in stable kidney transplant recipients (KTR). METHODS: A total of 709 stable outpatient KTR were enrolled >2 months post-transplant. The utility of plasma and urinary NGAL (pNGAL, uNGAL) and plasma and urinary CPT at enrollment to predict death-censored graft loss was evaluated during a 58-month follow-up. RESULTS: Among biomarkers, pNGAL showed the best predictive ability for graft loss and was the only biomarker with an area under the curve (AUC) > 0.7 for graft loss within 5 years. Patients with graft loss within 5 years (n = 49) had a median pNGAL of 304 [interquartile range (IQR) 235-358] versus 182 (IQR 128-246) ng/mL with surviving grafts (P < .001). Time-dependent receiver operating characteristic analyses at 58 months indicated an AUC for pNGAL of 0.795, serum creatinine-based Chronic Kidney Disease Epidemiology Collaboration estimated glomerular filtration rate (eGFR) had an AUC of 0.866. pNGAL added to a model based on conventional risk factors for graft loss with death as competing risk (age, transplant age, presence of donor-specific antibodies, presence of proteinuria, history of delayed graft function) had a strong independent association with graft loss {subdistribution hazard ratio (sHR) for binary log-transformed pNGAL [log2(pNGAL)] 3.4, 95% confidence interval (CI) 2.24-5.15, P < .0001}. This association was substantially attenuated when eGFR was added to the model [sHR for log2(pNGAL) 1.63, 95% CI 0.92-2.88, P = .095]. Category-free net reclassification improvement of a risk model including log2(pNGAL) in addition to conventional risk factors and eGFR was 54.3% (95% CI 9.2%-99.3%) but C-statistic did not improve significantly. CONCLUSIONS: pNGAL was an independent predictor of renal allograft loss in stable KTR from one transplant center but did not show consistent added value when compared with baseline predictors including the conventional marker eGFR. Future studies in larger cohorts are warranted.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Swolinsky JS, Hinz RM, Markus CE, et al. Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss. Nephrol Dial Transplant. 2024. PMID: 37858309. doi:10.1093/ndt/gfad226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。